Intrinsic Edge Capital Management LLC Amicus Therapeutics, Inc. Transaction History
Intrinsic Edge Capital Management LLC
- $471 Million
- Q1 2025
A detailed history of Intrinsic Edge Capital Management LLC transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Intrinsic Edge Capital Management LLC holds 873,900 shares of FOLD stock, worth $5.01 Million. This represents 1.52% of its overall portfolio holdings.
Number of Shares
873,900
Previous 673,900
29.68%
Holding current value
$5.01 Million
Previous $6.35 Million
12.33%
% of portfolio
1.52%
Previous 0.94%
Shares
2 transactions
Others Institutions Holding FOLD
# of Institutions
315Shares Held
319MCall Options Held
378KPut Options Held
575K-
Wellington Management Group LLP Boston, MA29.2MShares$167 Million0.05% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.1MShares$166 Million0.0% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$140 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY21.5MShares$123 Million7.33% of portfolio
-
Avoro Capital Advisors LLC New York, NY20.5MShares$117 Million2.71% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $1.61B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...